IRIS
CALZETTA, LUIGINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.614
EU - Europa 1.305
AS - Asia 984
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
AF - Africa 5
Totale 25.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.598
KR - Corea 470
CN - Cina 365
IE - Irlanda 331
UA - Ucraina 206
IT - Italia 191
DE - Germania 164
SG - Singapore 99
FR - Francia 88
GB - Regno Unito 85
SE - Svezia 62
RU - Federazione Russa 61
FI - Finlandia 48
PL - Polonia 21
BE - Belgio 14
CA - Canada 14
NL - Olanda 11
BR - Brasile 9
IN - India 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AU - Australia 8
CL - Cile 7
ES - Italia 5
GR - Grecia 5
HK - Hong Kong 5
MY - Malesia 5
RO - Romania 5
EC - Ecuador 4
EG - Egitto 4
ID - Indonesia 4
JO - Giordania 3
KH - Cambogia 3
AT - Austria 2
EU - Europa 2
IR - Iran 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
TR - Turchia 2
UZ - Uzbekistan 2
VN - Vietnam 2
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 25.947
Salva come PNG Salva come JPEG
Città #
Wilmington 7.199
Houston 7.101
Woodbridge 4.586
Fairfield 1.056
Ann Arbor 478
Chandler 478
Ashburn 450
Seattle 436
Cambridge 368
Dublin 253
Dearborn 214
Medford 187
Beijing 120
Jacksonville 92
Lawrence 92
New York 84
Rome 80
Zhengzhou 69
Singapore 58
San Diego 57
Menlo Park 41
Redwood City 30
Moscow 25
London 22
Kraków 20
Norwalk 20
Nanjing 18
Shanghai 18
Hefei 16
Guangzhou 15
Helsinki 15
Milan 15
Brussels 14
Hangzhou 14
Palo Alto 13
Seoul 13
Jinan 12
La Veta 11
Saint Petersburg 11
Mountain View 10
Verona 10
Wuhan 10
Boardman 9
Kunming 9
San Jose 9
Nanchang 8
Chengdu 7
Phoenix 7
São Paulo 7
Kilburn 6
Los Angeles 6
Toronto 6
Athens 5
Hamilton 5
Jiaxing 5
Nuremberg 5
Hong Kong 4
New Bedfont 4
Prescot 4
Redmond 4
San Francisco 4
Bari 3
Bologna 3
Cagliari 3
Chaah 3
Cuenca 3
Detroit 3
Frosinone 3
Fuzhou 3
Lappeenranta 3
Phnom Penh 3
Raleigh 3
San Mateo 3
Washington 3
Wenzhou 3
Acerra 2
Agropoli 2
Barga 2
Baulkham Hills 2
Birmingham 2
Coalville 2
Colorado Springs 2
Costa Mesa 2
Council Bluffs 2
Engelhard 2
Guiyang 2
Gunzenhausen 2
Hanoi 2
Hanover 2
Harbin 2
Islington 2
Jakarta 2
Kathmandu 2
Kuala Lumpur 2
Lamezia Terme 2
Las Vegas 2
Loecknitz 2
Melbourne 2
Nizhniy Novgorod 2
North Hollywood 2
Totale 24.037
Salva come PNG Salva come JPEG
Nome #
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 435
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 421
Optimizing drug delivery in COPD: The role of inhaler devices 419
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 416
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 414
Tiotropium formulations and safety: a network meta-analysis 412
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 408
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 404
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 404
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 403
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 403
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 402
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 402
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 400
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 399
Occupational allergy to horse allergens: More than exposure to horses! 398
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 390
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD 388
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 385
The Challenges of Precision Medicine in COPD 385
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 382
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience 375
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 370
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 370
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 361
null 359
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 357
Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? 357
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 355
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways 355
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 354
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis 351
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? 346
Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics 340
What could the role of can f 5 allergen be in dog-sensitized patients in “real life”? 338
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine 336
Partial renal resection by LaparoNewPro: in vivo open and laparoscopic study in an animal model 335
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 331
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis 331
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways 329
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? 329
Anaphylaxis and intimate behaviour 321
Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link? 321
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 319
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 317
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 317
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 312
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how 305
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis 297
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi 279
Is ICS–LAMA an alternative option to treat patients with COPD? 266
Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells 262
Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link? 247
Indoor environmental interventions for furry pet allergens: How to decrease the degree of passive transport 244
Geographical characteristics influencing the risk of poisoning in pet dogs: Results of a large population-based epidemiological study in Italy 242
The safety of dual bronchodilation on cardiovascular serious adverse events in COPD 241
How does race/ethnicity influence pharmacological response to asthma therapies? 240
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? 235
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: A quantitative synthesis 233
Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease 232
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 231
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 227
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment 212
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy): a multicenter study 209
Impact of doxofylline in COPD: A pairwise meta-analysis 208
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation 203
Olodaterol + tiotropium bromide for the treatment of COPD 199
Cardiovascular Disease in Chronic Respiratory Disorders and Beyond 198
Anxiety and asthma in inner-city black adolescents: What could be the underestimated, possible connection? 196
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review 195
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine 190
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease 189
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 189
Can f 5 as a suitable marker of dog allergy: Assess male dog exposure before banning it 184
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis 180
Bronchodilators in subjects with asthma-related comorbidities 177
Dog allergy: Can a prevalent or exclusive sensitization to can f 5 be considered a lucky or negative event in “real life”? 175
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple combination therapy in COPD 175
Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice? 170
Monoclonal antibodies in severe asthma: is it worth it? 168
Efficacy and safety profile of doxofylline compared to theophylline in asthma: A meta-analysis 156
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations 152
Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics 151
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis 151
Monoclonal antibodies for severe asthma: Pharmacokinetic profiles 149
Occupational exposure to furry animals and asthma: The complex interconnection between work and everyday life 142
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations 139
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 128
Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways 125
Response 116
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD 116
Sex differences in adult asthma and COPD therapy: a systematic review 30
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 26
Are there pulmonary sequelae in patients recovering from COVID-19? 21
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 19
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review 17
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 16
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 14
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 14
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 14
Totale 26.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.431 0 705 548 920 873 989 855 823 848 701 598 571
2020/20215.104 559 604 602 603 574 611 616 500 94 154 124 63
2021/2022951 78 83 19 21 26 114 64 42 52 131 111 210
2022/20231.160 121 95 40 156 106 275 99 62 121 5 45 35
2023/2024489 151 13 36 10 33 94 39 17 13 25 7 51
2024/2025110 98 12 0 0 0 0 0 0 0 0 0 0
Totale 26.394